الصفحة الرئيسية>>Signaling Pathways>> Obesity, Appetite Control & Diabetes>> NAFLD & NASH>>all-cis-4,7,10,13,16-Docosapentaenoic Acid

all-cis-4,7,10,13,16-Docosapentaenoic Acid (Synonyms: all-cis-4,7,10,13,16-DPA, Osbond Acid)

رقم الكتالوجGC40812

Docosapentaenoic acid (DPA) is a 22-carbon fatty acid found in fish oils.

Products are for research use only. Not for human use. We do not sell to patients.

all-cis-4,7,10,13,16-Docosapentaenoic Acid التركيب الكيميائي

Cas No.: 25182-74-5

الحجم السعر المخزون الكميّة
1mg
60٫00
متوفر
5mg
271٫00
متوفر
10mg
479٫00
متوفر
25mg
1051٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Docosapentaenoic acid (DPA) is a 22-carbon fatty acid found in fish oils. It is a minor constituent of the total serum unsaturated fatty acids in humans, ranging from 0.1 to 1%, and increases on dietary supplementation. all-cis-4,7,10,13,16-DPA, also known as osbond acid, is an isomer of DPA. It is an ω-6 fatty acid formed by the elongation and desaturation of arachidonic acid . Levels of this fatty acid may be diminished during fatty acid desaturase syndrome and this may affect development. Upregulated expression of hepatic elongation of very long fatty acids protein 6 and increased levels of very long chain fatty acids, including all-cis-4,7,10,13,16-DPA, are characteristic of non-alcoholic steatohepatitis, a preneoplastic condition of hepatocellular carcinoma.

مراجعات

Review for all-cis-4,7,10,13,16-Docosapentaenoic Acid

Average Rating: 5 ★★★★★ (Based on Reviews and 4 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for all-cis-4,7,10,13,16-Docosapentaenoic Acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.